Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Covington
Julphar
UBS
Medtronic
Cerilliant
Chubb
Chinese Patent Office
Federal Trade Commission

Generated: December 10, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MISOPROSTOL

« Back to Dashboard

Clinical Trials for Misoprostol

Trial ID Title Status Sponsor Phase Summary
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed Bill and Melinda Gates Foundation N/A Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed Global Network for Women's and Children's Health Research N/A Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed Jawaharlal Nehru Medical College N/A Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed John E. Fogarty International Center (FIC) N/A Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed National Cancer Institute (NCI) N/A Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed National Center for Complementary and Integrative Health (NCCIH) N/A Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
NCT00097123 RCT of Misoprostol for Postpartum Hemorrhage in India Completed National Institute of Dental and Craniofacial Research (NIDCR) N/A Death rates for pregnant women in rural India are approximately forty-five times higher than in the United States. Bleeding after the birth of a child and underlying anemia are the primary causes of mothers' deaths and sickness in rural India. This study assesses the effectiveness of an oral drug, misoprostol, given in the late stage of labor to reduce the incidence of maternal bleeding following births assisted by midwives in selected sites in Belgaum District, Karnataka, India.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Misoprostol

Condition Name

Condition Name for Misoprostol
Intervention Trials
Postpartum Hemorrhage 32
Cervical Ripening 19
Pregnancy 16
Abortion, Induced 16
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Misoprostol
Intervention Trials
Hemorrhage 67
Postpartum Hemorrhage 52
Abortion, Spontaneous 14
Abortion, Missed 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Misoprostol

Trials by Country

Trials by Country for Misoprostol
Location Trials
United States 164
Egypt 62
Vietnam 12
Canada 10
India 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Misoprostol
Location Trials
California 19
Pennsylvania 13
New York 11
Illinois 11
Texas 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Misoprostol

Clinical Trial Phase

Clinical Trial Phase for Misoprostol
Clinical Trial Phase Trials
Phase 4 78
Phase 3 60
Phase 2/Phase 3 19
[disabled in preview] 49
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Misoprostol
Clinical Trial Phase Trials
Completed 165
Recruiting 65
Not yet recruiting 34
[disabled in preview] 45
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Misoprostol

Sponsor Name

Sponsor Name for Misoprostol
Sponsor Trials
Gynuity Health Projects 55
Ain Shams University 18
Assiut University 16
[disabled in preview] 38
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Misoprostol
Sponsor Trials
Other 453
Industry 16
NIH 10
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Boehringer Ingelheim
Merck
Chubb
Queensland Health
Accenture
Daiichi Sankyo
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.